Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors

por Switzer, Benjamin, Haanen, John, Lorigan, Paul C, Puzanov, Igor, Turajlic, Samra
Publicado 2021

Autoimmune fasciitis triggered by the anti-programmed cell death-1 monoclonal antibody nivolumab

por Parker, Matthew JS, Roberts, Mark E, Lorigan, Paul C, du Plessis, Daniel G, Chinoy, Hector
Publicado 2018

T cell immune awakening in response to immunotherapy is age-dependent

por Salih, Zena, Banyard, Antonia, Tweedy, Joshua, Galvani, Elena, Middlehurst, Philippa, Mills, Sarah, Weightman, John, Gupta, Avinash, Lorigan, Paul C., Zhou, Cong, Dhomen, Nathalie, Valpione, Sara, Marais, Richard
Publicado 2022

Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy

por Valpione, Sara, Galvani, Elena, Tweedy, Joshua, Mundra, Piyushkumar A., Banyard, Antonia, Middlehurst, Philippa, Barry, Jeff, Mills, Sarah, Salih, Zena, Weightman, John, Gupta, Avinash, Gremel, Gabriela, Baenke, Franziska, Dhomen, Nathalie, Lorigan, Paul C., Marais, Richard
Publicado 2020

Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study

por Hamid, Omid, Hassel, Jessica C, Shoushtari, Alexander N, Meier, Friedegund, Bauer, Todd M, Salama, April K S, Kirkwood, John M, Ascierto, Paolo A, Lorigan, Paul C, Mauch, Cornelia, Orloff, Marlana, Evans, Thomas R Jeffry, Holland, Chris, Edukulla, Ramakrishna, Abedin, Shaad E, Middleton, Mark R
Publicado 2023

Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant...

por Garbe, Claus, Keim, Ulrike, Amaral, Teresa, Berking, Carola, Eigentler, Thomas K., Flatz, Lukas, Gesierich, Anja, Leiter, Ulrike, Stadler, Rudolf, Sunderkötter, Cord, Tüting, Thomas, Utikal, Jochen, Wollina, Uwe, Zimmer, Lisa, Zouboulis, Christos C., Ascierto, Paolo A., Eggermont, Alexander M.M., Grob, Jean-Jacques, Hauschild, Axel, Sekulovic, Lidija Kandolf, Long, Georgina V., Luke, Jason J., Michielin, Olivier, Peris, Ketty, Schadendorf, Dirk, Kirkwood, John M., Lorigan, Paul C.
Publicado 2022

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary An...

por Eggermont, Alexander M. M., Kicinski, Michal, Blank, Christian U., Mandala, Mario, Long, Georgina V., Atkinson, Victoria, Dalle, Stéphane, Haydon, Andrew, Khattak, Adnan, Carlino, Matteo S., Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A., Rutkowski, Piotr, Schadendorf, Dirk, Koornstra, Rutger, Hernandez-Aya, Leonel, Di Giacomo, Anna Maria, van den Eertwegh, Alfonsus J. M., Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Lorigan, Paul C., Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, van Akkooi, Alexander, Robert, Caroline, Suciu, Stefan
Publicado 2020

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

por Eggermont, Alexander M. M., Blank, Christian U., Mandala, Mario, Long, Georgina V., Atkinson, Victoria G., Dalle, Stéphane, Haydon, Andrew M., Meshcheryakov, Andrey, Khattak, Adnan, Carlino, Matteo S., Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A., Rutkowski, Piotr, Schadendorf, Dirk, Koornstra, Rutger, Hernandez-Aya, Leonel, Di Giacomo, Anna Maria, van den Eertwegh, Alfonsus J. M., Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Lorigan, Paul C., van Akkooi, Alexander C. J., Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, Kicinski, Michal, Suciu, Stefan, Robert, Caroline
Publicado 2020

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma

por Bhave, Prachi, Ahmed, Tasnia, Lo, Serigne N, Shoushtari, Alexander, Zaremba, Anne, Versluis, Judith M, Mangana, Joanna, Weichenthal, Michael, Si, Lu, Lesimple, Thierry, Robert, Caroline, Trojanello, Claudia, Wicky, Alexandre, Heywood, Richard, Tran, Lena, Batty, Kathleen, Dimitriou, Florentia, Stansfeld, Anna, Allayous, Clara, Schwarze, Julia K, Mooradian, Meghan J, Klein, Oliver, Mehmi, Inderjit, Roberts-Thomson, Rachel, Maurichi, Andrea, Yeoh, Hui-Ling, Khattak, Adnan, Zimmer, Lisa, Blank, Christian U, Ramelyte, Egle, Kähler, Katharina C, Roy, Severine, Ascierto, Paolo A, Michielin, Olivier, Lorigan, Paul C, Johnson, Douglas B, Plummer, Ruth, Lebbe, Celeste, Neyns, Bart, Sullivan, Ryan, Hamid, Omid, Santinami, Mario, McArthur, Grant A, Haydon, Andrew M, Long, Georgina V, Menzies, Alexander M, Carlino, Matteo S
Publicado 2022

Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

por Rogiers, Aljosja, Pires da Silva, Ines, Tentori, Chiara, Tondini, Carlo Alberto, Grimes, Joseph M, Trager, Megan H, Nahm, Sharon, Zubiri, Leyre, Manos, Michael, Bowling, Peter, Elkrief, Arielle, Papneja, Neha, Vitale, Maria Grazia, Rose, April A N, Borgers, Jessica S W, Roy, Severine, Mangana, Joanna, Pimentel Muniz, Thiago, Cooksley, Tim, Lupu, Jeremy, Vaisman, Alon, Saibil, Samuel D, Butler, Marcus O, Menzies, Alexander M, Carlino, Matteo S, Erdmann, Michael, Berking, Carola, Zimmer, Lisa, Schadendorf, Dirk, Pala, Laura, Queirolo, Paola, Posch, Christian, Hauschild, Axel, Dummer, Reinhard, Haanen, John, Blank, Christian U, Robert, Caroline, Sullivan, Ryan J, Ascierto, Paolo Antonio, Miller Jr, Wilson H, Stephen Hodi, F, Suijkerbuijk, Karijn P M, Reynolds, Kerry L, Rahma, Osama E, Lorigan, Paul C, Carvajal, Richard D, Lo, Serigne, Mandala, Mario, Long, Georgina V
Publicado 2021